Title : Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus.

Pub. Date : 2018 Aug

PMID : 29977423






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Background: Anagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor expected to improve the lipid profile as well as glycemic control. anagliptin dipeptidyl peptidase 4 Homo sapiens
2 Background: Anagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor expected to improve the lipid profile as well as glycemic control. anagliptin dipeptidyl peptidase 4 Homo sapiens